Answers are grounded in this paper and cite their sources.
In only two steps the commercially available maleimide 1 is converted into the key pyrrolizidine carboxylic acid unit (2) of the telomerase inhibitor UCS1025A. A kinetic resolution through an enantioselective oxa-Michael lactonization and trituration of the resulting scalemic mixture allow for a virtually quantitative separation of a racemate into the enantiomers.
No takes yet. Share an insight, caveat, or question.
Figueiredo et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: